Butterfly Network, Inc.
BFLY
NYSE·Healthcare·Medical - Devices·Mkt cap $2.0B
$7.36
▲ +0.96%
P/E
-25.43
Mkt Cap
$2.0B
52-Wk Range
$1.47–$10.05
52-Week Range
$1.47 - $10.05
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 362.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Proprietary single-probe whole-body ultrasound technology enabling portability and ease-of-use
- Smartphone and tablet integration reducing capital expenditure and expanding addressable market
- Integrated software ecosystem (Compass, Blueprint) creating healthcare system lock-in and recurring revenue
- Established direct sales force and multi-channel distribution strategy
- Clinical education platform (Butterfly Academy) building user loyalty and expanding adoption
Bear Case
1 risk
- High volatility (beta 2.1). Larger-than-normal price swings expected.
Growth
Stable outlook
Expansion of point-of-care ultrasound adoption in emergency departments, primary care, and rural healthcare
Value
Deep value opportunity - significant discount to Medical Devices peers
Momentum
Hot
+61.0% over 3m
Quality
Strong
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying BFLY right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 30, 2026
JUL 30, 2026
Reported EPS of -$0.01 vs -$0.04 consensus (+71.4% surprise). Revenue of $32.6M vs $29.2M expected (+11.8%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+71.4%
Revenue trend · last 8Q
—
+35%
+20%
+9%
+5%
+41%
+25%
+39%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$20.6M
$22.4M
$21.2M
$23.4M
$21.5M
$31.5M
$26.5M
$32.6M
Margins · last 8Q
Gross
71.4%
Operating
-41.9%
Profit
-39.6%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How BFLY stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related